biotech
EVP of Diabetes decamps from Sanofi to become Almirall CEO
August 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
FDA approves first treatment for the ‘silent killer’
August 30, 2017Research and Development, Sales and Marketing Chagas disease, FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced that it has granted an accelerated approval for the use of benznidazole in children between the ages …
UK’s post-Brexit strategy looks to life sciences industry
August 30, 2017Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical
The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …
AstraZeneca unloads another drug for $400m
August 29, 2017Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical
AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …
Thyroid disorders: An illness underestimated
August 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …
Novartis’ drug prevents heart attacks and cancer but faces major challenges
August 29, 2017Manufacturing and Production, Research and Development Novartis, biotech, drugs, pharma, pharmaceutical
It would be expected that when a company releases data to show that its drug, previously only used in a …
Gilead captures Kite in $11.9bn deal
August 29, 2017Manufacturing and Production, Sales and Marketing Gilead, biotech, drugs, kite pharma, pharma, pharmaceutical
Gilead had long been expected to make a serious acquisition to boost flagging growth and it finally made a move …
Lithium levels in water supply could prevent dementia
August 25, 2017Research and Development biotech, drugs, lithium, pharma, pharmaceutical
Lithium has long been used in the treatment of people living with bipolar disorder and animal studies have found potential …
The pharmacovigilance market dynamic
August 25, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, pharmacoviglance
Pharmacovigilance is a science of understanding drug safety through identification, assessment, and prevention of adverse drug reactions (ADRs). It is …
Seven years later, EC gives approval for Merck KGaA’s MS drug
August 25, 2017Medical Communications, Sales and Marketing Mavenclad, Merck KGaA, biotech, drugs, multiple sclerosis, pharma, pharmaceutical
In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …
Samsung completes hat-trick of big biosimilar approvals
August 25, 2017Medical Communications, Sales and Marketing Biogen, Samsung Bioepis, biosimilars, biotech, drugs, pharma, pharmaceutical
Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …
‘Trade secret information’ to be shared between EMA and FDA
August 25, 2017Manufacturing and Production, Medical Communications EMA, FDA, biotech, drugs, pharma, pharmaceutical
As part of the on-going harmonisation of manufacturing standards across the Atlantic, the EMA and FDA have announced that they …
Roche receives FDA Priority Review for drug with potted history
August 24, 2017Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical
Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …
HIV home tests seized from market over potential risk
August 24, 2017Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical
The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …
Novartis gets EU nod for potential blockbuster breast cancer drug
August 24, 2017Sales and Marketing CDK4/6, Novartis, biotech, breast cancer, drugs, pharma, pharmaceutical
Novartis has released that it has received marketing approval from the European Commission for its drug for the treatment of …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
